Efficacy of probing adjunctive with low-dose mitomycin-C irrigation for the treatment of epiphora in adults with nasolacrimal duct stenosis

被引:0
|
作者
Masoomian, Babak [1 ]
Eshraghi, Bahram [1 ]
Latifi, Golshan [1 ]
Esfandiari, Hossein [1 ]
机构
[1] Univ Tehran Med Sci, Farabi Eye Hosp, Kargar St,Qazvin Sq, Tehran, Iran
关键词
Adults; epiphora; mitomycin-C; nasolacrimal duct stenosis; probing; SILICONE INTUBATION; DACRYOCYSTORHINOSTOMY; SUCCESS;
D O I
10.4103/tjo.tjo_25_20
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
PURPOSE: The purpose of the study was to investigate the efficacy of adjunctive low-dose mitomycin-C (MMC) during successful lacrimal duct probing in adults with nasolacrimal ducts (NLDs) stenosis. MATERIALS AND METHODS: This is a prospective case-control study on patients with NLD stenosis who were randomized into two groups. All patients underwent probing without or with an application of MMC. Former group received 0.2 mg/ml MMC irrigation for 5 min. The main outcome measures were objective evaluation of patency with irrigation, as well as patients' subjective assessment of improvement. RESULTS: There were 73 eyes in 58 consecutive patients; patient mean age ranged from 19 to 78 years (mean 44 years). Female included larger group of patients (63%) and mean duration of the symptoms was 26.1 months (range, 2-120 months). After mean follow-up of 11 months (range, 9-14 months), 23 (60%) of the 38 eyes in the MMC groups and 8 (22%) of the 35 eyes in control group had complete response and remained symptom free. This difference was statistically significant (P = 0.005). According to the patient's satisfaction, epiphora was partially improved in 6 (17%) eyes of control group and 4 (10%) eyes in MMC group. Application of MMC has a better outcome in patients with severe stenosis (P = 0.007); patients who had symptoms more than 12 months (P = 0.02) and patients with constant epiphora were compared with intermittent symptoms (P = 0.001). No complications were detected during patients follow-up. CONCLUSION: This study suggests acceptable long-term results for probing adjunctive with MMC irrigation for adults with NLD stenosis that can be recommended as a simple and effective procedure for these patients.
引用
收藏
页码:287 / 291
页数:5
相关论文
共 44 条
  • [21] Evaluation of limbal conjunctival autograft and low-dose mitomycin C in the treatment of recurrent pterygium
    Nabawi, KS
    Ghonim, MA
    Ali, MH
    OPHTHALMIC SURGERY LASERS & IMAGING, 2003, 34 (03): : 193 - 196
  • [22] DRUG RESISTANCE RESTRICTS THE EFFICACY OF SHORT TERM LOW DOSE MITOMYCIN-C TREATMENT IN UMUC-3 BLADDER CANCER CELLS
    Gul, Murat
    Goktas, Serdar
    Kars, Meltem Demirel
    Kaynar, Mehmet
    ARCHIVOS ESPANOLES DE UROLOGIA, 2018, 71 (09): : 783 - 793
  • [23] LOW-DOSE VS HIGH-DOSE MITOMYCIN-C WITH GLAUCOMA FILTRATION SURGERY IN PATIENTS WITH PRIMARY OPEN-ANGLE GLAUCOMA
    TWER, A
    ANAND, R
    KOONER, KS
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 1994, 35 (04) : 1429 - 1429
  • [24] Comparison of low-dose intraoperative mitomycin-C vs 5-fluorouracil in primary glaucoma surgery: A pilot study
    Vijaya, L
    Mukhesh, BN
    Shantha, B
    Ramalingam, S
    Devi, AVS
    OPHTHALMIC SURGERY AND LASERS, 2000, 31 (01): : 24 - 30
  • [25] LABORATORY CORRELATES OF CHEMOIMMUNOTHERAPY WITH LOW-DOSE RECOMBINANT INTERLEUKIN-2 AND MITOMYCIN-C IN PATIENTS WITH ADVANCED-CARCINOMA
    ARINAGA, S
    KARIMINE, N
    TAKAMUKU, K
    NANBARA, S
    INOUE, H
    ABE, R
    WATANABE, D
    ASOH, T
    UEO, H
    AKIYOSHI, T
    CANCER INVESTIGATION, 1994, 12 (06) : 588 - 596
  • [26] Low-dose intraoperative mitomycin-C versus conjunctival autograft in primary pterygium surgery: Long term follow-up
    Sharma, A
    Gupta, A
    Ram, J
    Gupta, A
    OPHTHALMIC SURGERY AND LASERS, 2000, 31 (04): : 301 - 307
  • [27] Combined 'symmetrical conjunctival flap transposition' and intraoperative low-dose mitomycin C in the treatment of primary pterygium
    Uçakhan, ÖÖ
    Kanpolat, A
    CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY, 2006, 34 (03): : 219 - 225
  • [28] A PHASE-II STUDY OF LOW-DOSE MITOMYCIN-C (MITO) IN CHEMOTHERAPY-REFRACTORY METASTATIC BREAST-CANCER PATIENTS
    CREECH, RH
    CATALANO, RB
    SHAH, MK
    DAYAL, H
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1981, 22 (MAR): : 439 - 439
  • [29] Apoptosis of bladder cancer cells induced by short-term and low-dose Mitomycin-C: Potential molecular mechanism and clinical implication
    Liu, J
    Wang, Q
    Wang, XW
    Sun, Y
    Chen, XY
    Kong, QY
    Zhang, KL
    Li, H
    INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE, 2003, 11 (03) : 389 - 394
  • [30] Efficacy and Safety of Low-Dose Tirofiban for Acute Intracranial Atherosclerotic Stenosis Related Occlusion with Residual Stenosis after Endovascular Treatment
    Yan, Zhizhong
    Shi, Zhonghua
    Wang, Yuhai
    Zhang, Chunlei
    Cao, Jiaming
    Ding, Chunlong
    Qu, Mirui
    Xia, Yunbao
    Cai, Jin
    Zhang, Xin
    Wang, Handong
    JOURNAL OF STROKE & CEREBROVASCULAR DISEASES, 2020, 29 (04):